PLA2G4A and acute myeloid leukemia: PLA2G4A, a member of the cytosolic phospholipase that catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid, increased by 7.21 fold, representing one of the most upregulated genes in AML patients with poor prognosis (Figures 2A, 5A).